Evommune Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023
Period Ending	Apr '26 Apr 15, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Market Capitalization	970	540	-	-
Enterprise Value	834	721	-	-
Last Close Price	26.63	17.12	-	-
PS Ratio	75.50	41.52	-	-
PB Ratio	4.08	2.63	-	-
P/TBV Ratio	4.77	2.63	-	-
EV/Sales Ratio	64.18	55.49	-	-
Debt / Equity Ratio	0.01	0.01	0.01	0.02
Net Debt / Equity Ratio	-0.72	-0.72	-1.50	-1.09
Net Debt / EBITDA Ratio	1.85	1.85	1.04	2.11
Net Debt / FCF Ratio	1.92	1.92	1.23	2.59
Asset Turnover	0.09	0.09	0.09	-
Quick Ratio	8.33	8.33	2.58	11.53
Current Ratio	8.57	8.57	2.64	11.67
Return on Equity (ROE)	-54.42%	-54.42%	-112.09%	-
Return on Assets (ROA)	-33.67%	-33.67%	-55.28%	-
Return on Capital Employed (ROCE)	-39.20%	-39.20%	-145.60%	-50.20%
Earnings Yield	-7.02%	-12.76%	-	-
FCF Yield	-7.81%	-14.21%	-	-
Buyback Yield / Dilution	-306.86%	-306.86%	-20.35%	-

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q